Drug Shortage Report for SANDOZ AMPHETAMINE XR

Last updated on 2019-01-16 History
Report ID 59549
Drug Identification Number 02457342
Brand name SANDOZ AMPHETAMINE XR
Common or Proper name AMPHETAMINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DEXTROAMPHETAMINE SACCHARATE DEXTROAMPHETAMINE SULFATE AMPHETAMINE ASPARTATE MONOHYDRATE AMPHETAMINE SULFATE
Strength(s) 7.5MG 7.5MG 7.5MG 7.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100S
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-09-17
Estimated end date 2018-12-17
Actual end date 2018-12-31
Shortage status Resolved
Updated date 2019-01-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-01-16 French Compare
v11 2019-01-16 English Compare
v10 2018-11-12 French Compare
v9 2018-11-12 English Compare
v8 2018-09-28 French Compare
v7 2018-09-28 English Compare
v6 2018-09-18 French Compare
v5 2018-09-10 French Compare
v4 2018-09-10 English Compare
v3 2018-09-01 English Compare
v2 2018-08-29 French Compare
v1 2018-08-29 English Compare

Showing 1 to 12 of 12